Specific lymphomatous infiltration of the skin by Hodgkin's disease is rare and is usually a sign of uncontrolled recurrent disease. Distant cutaneous infiltration may occur preterminally in patients with widespread disease. I now report an exception: disseminated skin lesions regressed spontaneously in a patient who had been treated for stage IA disease. He has remained free of the disease for two and a half years.
Case report
A 46-year-old milkman presented with a mass in the left axilla. At about the same time he developed total alopecia affecting all body hair. Lymphnode biopsy showed infiltration by Hodgkin's disease of mixed cellularity type. There were no systemic symptoms or other clinical evidence of Hodgkin's disease. Chest radiography, lymphography, and intravenous pyelography showed no abnormalities. Erythrocyte sedimentation rate was 83 mm in the first hour. No abnormality was found at laparotomy, and the patient was pathologically staged as having stage IA disease. Mantle irradiation was administered, delivering a dose of 40 Gy (4000 rad) to the midpoint of the chest in 20 fractions over 28 days.
At the completion of radiotherapy a rash was noted. This began on the lower abdomen and left groin and spread to the front of the thighs and the buttocks (see figure) . There was an isolated nodule on the left elbow. Thẽ~~~~~~~~~~~~~~~~Ĩ nfiltrated papules of cutaneous Hodgkin's disease with coincidental alopecia. lesions were discrete infiltrated papules, up to 8 mm in diameter, of a livid red to flesh colour. There was no vesiculation to suggest herpes zoster, and a specific infiltration of the skin by diseased cells was diagnosed clinically. Examination of a biopsy specimen of one of the abdominal lesions showed that the dermis was infiltrated by lymphocytes, plasma cells, eosinophils, mononuclear Hodgkin's cells, and classical binucleate Reed-Sternberg cells. There was no other clinical evidence of Hodgkin's disease; the lymphogram remained normal and the erythrocyte sedimentation rate had fallen to 29 mm in the first hour. The skin nodules resolved spontaneously within one month. At about the same time the patient's hair started to regrow. Alopecia areata was diagnosed retrospectively and thought to be coincidental. There has been no further evidence of recurrent Hodgkin's disease two and a half years after treatment.
Comment
Non-specific cutaneous lesions occur in 13-53 % of cases of Hodgkin's disease. The skin is not histologically affected, and the commonest lesions are prurigo-like papules, herpes zoster, increased pigmentation, and exfoliative dermatitis.1 Specific lymphomatous infiltration of the skin is rarer and usually occurs as an extension of uncontrolled infiltration of adjacent lymph nodes.' The skin may also become infiltrated distal to massive nodal disease, and in such cases retrograde lymphatic spread has been suggested.2 Surgical implantation of lymphomatous tissue in the skin may occur, especially after repeated biopsy or attempted block dissection.
Cutaneous Hodgkin's disease as the sole evidence of recurrence has been reported by Rubins.3 His patient developed widespread skin lesions unrelated to initial nodal disease, which was in remission after radiotherapy. Sequential single-agent chemotherapy administered over four years controlled the disease but did not eradicate it. Primary cutaneous Hodgkin's disease is rare and may have a good prognosis. Only 17 cases have been reported.4 This type of Hodgkin's disease may suggest an unusual relation between tumour and host. It probably arises by the haematogenous route, the lymphoma being localised by organ-specific factors. Szur et a15 observed three such patients for several years: there was no evidence to suggest that other organs were affected, and two patients showed spontaneous partial regression and remained untreated.
Biopsy is essential in the diagnosis of cutaneous Hodgkin's disease. After staging the disease, treatment should be dictated by the extent to which other organs are affected. If only the skin is affected a period of observation is indicated unless the lesions are symptomatic. We describe here an example of the problem, and using strict criteria we now think that 12 (not 16) of the 110 women in our 1979 paper' were probably immunised during, and not after, the immunising pregnancy. Moreover, in most of them antibodies were found only after the 28th week and therefore antenatal anti-D should have helped. There is good evidence from other countries that antenatal anti-D given at about the 28th and 34th weeks, in addition to the routine postnatal dose, can substantially reduce the small failure rate of the standard postnatal programme.2
The easiest patients to assess are those in whom antibodies are found during the first pregnancy, the baby being rhesus positive and the mother never having had a transfusion of rhesus-positive blood. There is then strong evidence that the primary immunisation did occur before term. On the other hand, if antibodies are first found during a second or subsequent pregnancy, there is always the possibility that they may have been formed in response to an earlier stimulus, the antibodies not necessarily being serologically detectable at this time ("sensibilisation"). 
